Literature DB >> 22010174

Re: a case-control study of levothyroxine and the risk of colorectal cancer.

Gary D Friedman, Joan S Schwalbe, Laurel A Habel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22010174      PMCID： PMC3206041          DOI： 10.1093/jnci/djr374

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

Review 1.  Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.

Authors:  Gary D Friedman; Natalia Udaltsova; James Chan; Charles P Quesenberry; Laurel A Habel
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

2.  A case-control study of levothyroxine and the risk of colorectal cancer.

Authors:  Gad Rennert; Hedy S Rennert; Mila Pinchev; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2010-03-19       Impact factor: 13.506
  2 in total
  4 in total

Review 1.  The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum.

Authors:  Maria V Deligiorgi; Dimitrios T Trafalis
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

2.  Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in ApcΔ716 mutant mice.

Authors:  Yasushi Kojima; Yuriko Kondo; Teruaki Fujishita; Emi Mishiro-Sato; Rie Kajino-Sakamoto; Makoto Mark Taketo; Masahiro Aoki
Journal:  Cancer Sci       Date:  2019-07-07       Impact factor: 6.716

3.  Levothyroxine use and the risk of colorectal cancer: a large population-based case-control study.

Authors:  Josephina G Kuiper; Aline C Fenneman; Anne H van der Spek; Elena Rampanelli; Max Nieuwdorp; Myrthe P P van Herk-Sukel; Valery E P P Lemmens; Ernst J Kuipers; Ron M C Herings; Eric Fliers
Journal:  Endocr Connect       Date:  2022-01-20       Impact factor: 3.335

4.  TSH-TSHR axis promotes tumor immune evasion.

Authors:  Zhenghao Wu; Zihan Xi; Yunxiao Xiao; Xiangwang Zhao; Jiexiao Li; Nan Feng; Longqing Hu; Renjing Zheng; Ning Zhang; Shuntao Wang; Tao Huang
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.